We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.


Refine your search

Content type

224 results found


Hogan Lovells | USA | 1 Jun 2017

FDA Begins Reorganization that Will Affect How it Regulates Medical Technology

The U.S. Food and Drug Administration (FDA) has undertaken significant reorganization efforts this year that affect the way it regulates medical


Squire Patton Boggs | USA | 22 May 2017

FDA User Fee Reauthorization Moves to Full Committee; HHS Further Delays Bundled Payment Models and Changes to 340B Drug Discount Program

While passing health reform through Congress has been a struggle, the Food and Drug Administration (FDA) user fee legislation has


Squire Patton Boggs | USA | 15 May 2017

Ways and Means to Hold First Hearing on Tax Reform

On Wednesday, May 17, the House Ways and Means Committee has scheduled a hearing titled “Opportunities for


Squire Patton Boggs | USA | 15 May 2017

Senate Finance to Discuss CHRONIC Care Act

On Tuesday, May 16, the Senate Committee on Finance will hold a hearing titled “Examining Bipartisan Medicare Policies that Improve Care for Patients


Squire Patton Boggs | USA | 1 May 2017

AHCA’s Final Act?; CMS Gathers Feedback and Issues Payment Rates for SNFs, IRFs, and Hospices

On Friday, April 28, Congress passed a short-term Continuing Resolution (CR) to fund the government until


Mintz | USA | 28 Mar 2017

FDA User Fee Hearings Picking Up Steam on Capitol Hill

As we noted previously in our introductory blog post on the 2017 User Fee Act (UFA) reauthorization process, the first UFA hearing on Capitol Hill


Squire Patton Boggs | USA | 27 Mar 2017

Health Reform Benched By Republican Leadership

Repealing and replacing the Affordable Care Act (ACA) has been the goal of Republicans in Congress for the last seven years.


Reed Smith LLP | USA | 21 Mar 2017

Congressional Panels Examining Pharmaceutical Distribution Systems, FDA Drug User Fees

Two Congressional committees are holding hearings this week on FDA user fees: a March 21 Senate Health, Education, Labor, and Pensions Committee


Squire Patton Boggs | USA | 20 Mar 2017

The AHCA: On to Rules Committee and House Floor; The Third Prong: Additional Legislation; HRSA Further Delays 340B Final Rule

The American Health Care Act (AHCA) continues to make its way through the legislative process. After surviving markups in the House Committee on


Baker & Hostetler LLP | USA | 28 Feb 2017

Capitol Hill Healthcare Update

President Trump will address a joint session of Congress on Tuesday, and the expectation is that he will